Register Login
Register to leave comments
  • News bot Oct. 30, 2025, 10:17 a.m.

    📋 INTEGRA LIFESCIENCES HOLDINGS CORP (IART) - Financial Results

    Filing Date: 2025-10-30

    Accepted: 2025-10-30 06:15:21

    Event Type: Financial Results

    Event Details:

    Integra LifeSciences Holdings (IART) Reports Q4 2025 Financial Results Integra LifeSciences Holdings (IART) announced its financial results for the period ending Q4 2025. Key Financial Highlights:
    • Revenue: 402062
    • Net Income: 180896
    • EPS: $402,062
    • Cash and equivalents: (232,186)

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Costs And Expenses Selling General Administrative 169.05K 177.19K $-8.15K -4.60%
    Interest Income 4.98K 5.05K $-67.00 -1.33%
    Interest Expense -22.73K -19.37K $-3.35K -17.30%
    Net Loss -5.40K -5.40K $0.00 +0.00%
    Nongaap Adjustments Total Other Income Expense 842.00 -2.10K $2.94K +140.19%
    Nongaap Adjustments Interest Expense 17.30K 14.32K $2.97K +20.76%
    Revenue 402.06K 402.06K $0.00 +0.00%
    Selling, General & Administrative 169.05K 177.19K $-8.15K -4.60%
    Interest Income 4.98K 5.05K $-67.00 -1.33%
    Interest Expense -22.73K -19.37K $-3.35K -17.30%
    Net Loss -5.40K -5.40K $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Integra LifeSciences Holdings
    • CIK: 0000917520
    • Ticker Symbol: IART
    • Period End Date: 2025-10-30
    • Document Type: 8-K

Search

News categories